Literature DB >> 24342162

Treatment of renal angiomyolipoma: surgery versus angioembolization.

P Urciuoli, V D'Orazi, G Livadoti, E Foresi, A Panunzi, S Anichini, M Cialini, A Wlderk, C Cirelli, M Colangelo, M Mongardini, F Custureri.   

Abstract

Renal angiomyolipoma (AML) is a benign mesenchymal tumour. AML often leads to haemorrhagic complications such as retroperitoneal haematoma. Treatment varies from case to case, ranging from minimally invasive approaches such as selective embolization of the renal artery to invasive wedge resection, partial nephrectomy or, in more severe cases, radical nephrectomy. Here we report a case of retroperitoneal haematoma secondary to AML, treated with conservative approach by super-selective embolization of the lower-pole segmental renal artery.

Entities:  

Mesh:

Year:  2013        PMID: 24342162      PMCID: PMC3926473     

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  24 in total

1.  Various appearances of multiple angiomyolipomas in the same kidney in a patient without tuberous sclerosis.

Authors:  Zeev V Maizlin; Paul Gottlieb; Yehudit Corat-Simon; Simon Strauss
Journal:  J Ultrasound Med       Date:  2002-02       Impact factor: 2.153

2.  Management of renal angiomyolipoma in patients with tuberous sclerosis complex.

Authors:  J L Simmons; S A Hussain; P Riley; D M A Wallace
Journal:  Oncol Rep       Date:  2003 Jan-Feb       Impact factor: 3.906

3.  Aggressive renal angiomyolipoma extending into the renal vein and inferior vena cava - an uncommon entity.

Authors:  S S Bakshi; K Vishal; V Kalia; J S Gill
Journal:  Br J Radiol       Date:  2011-08       Impact factor: 3.039

4.  Etiology of spontaneous perirenal hemorrhage: a meta-analysis.

Authors:  Jian Qing Zhang; Julia R Fielding; Kelly H Zou
Journal:  J Urol       Date:  2002-04       Impact factor: 7.450

5.  Chromosomal analysis of renal angiomyolipoma by comparative genomic hybridization: evidence for clonal origin.

Authors:  M M Kattar; D J Grignon; J N Eble; P M Hurley; P E Lewis; W E Sakr; M L Cher
Journal:  Hum Pathol       Date:  1999-03       Impact factor: 3.466

6.  Giant abdominopelvic epithelioid angiomyolipoma associated with tuberous sclerosis: report of a case.

Authors:  G Di Matteo; A Maturo; A Marzullo; N Peparini; B M Wedard; K P Zeri; F M Di Matteo; D Mascagni
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

7.  Treatment of angiomyolipoma at a tertiary care centre: the decision between surgery and angioembolization.

Authors:  Stephen Faddegon; Alan So
Journal:  Can Urol Assoc J       Date:  2011-03-01       Impact factor: 1.862

8.  Management of renal angiomyolipomas associated with tuberous sclerosis complex.

Authors:  Toru Harabayashi; Nobuo Shinohara; Hidenori Katano; Katsuya Nonomura; Tadashi Shimizu; Tomohiko Koyanagi
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

9.  Trends of presentation and clinical outcome of treated renal angiomyolipoma.

Authors:  Kyo Chul Koo; Won Tae Kim; Won Sik Ham; Jin Sun Lee; Hee Jeong Ju; Young Deuk Choi
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

10.  Renal angiomyolipoma: long-term results following selective arterial embolization.

Authors:  Jacob Ramon; Uri Rimon; Alex Garniek; Gil Golan; Paul Bensaid; Noam D Kitrey; Andrei Nadu; Zohar A Dotan
Journal:  Eur Urol       Date:  2008-04-18       Impact factor: 20.096

View more
  11 in total

1.  Use of loupes magnification and microsurgical technique in thyroid surgery: ten years experience in a single center.

Authors:  V D'Orazi; A Panunzi; E Di Lorenzo; Al Ortensi; M Cialini; S Anichini; A Ortensi
Journal:  G Chir       Date:  2016 May-Jun

2.  Embolization of symptomatic renal angiomyolipoma with a mixture of lipiodol and PVA, a mid-term result.

Authors:  Qiang Huang; Ren-You Zhai
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

3.  Selective Arterial Embolization of Giant Renal Angiomyolipoma Associated with Tuberous Sclerosis Complex Using Particular and Liquid Embolic Agents.

Authors:  Deniz Ozturk Kocakgol; Erdem Cayli; Sukru Oguz; Hasan Dinc
Journal:  Eurasian J Med       Date:  2018-06-01

Review 4.  Changing etiology and management patterns for spontaneous renal hemorrhage: a systematic review of contemporary series.

Authors:  Thomas Ahn; Matthew J Roberts; Anojan Navaratnam; Eric Chung; Simon Wood
Journal:  Int Urol Nephrol       Date:  2017-09-04       Impact factor: 2.370

5.  Optimal Ethanol-Ethiodol Emulsion Ratio in Renal Angiomyolipoma Embolization: A Question that Remains Unanswered.

Authors:  Sreeja Sanampudi; Driss Raissi
Journal:  J Clin Imaging Sci       Date:  2019-05-24

6.  Spontaneous rupture of large bilateral renal angiomyolipomas in a patient with tuberous sclerosis complex: A case report and literature review.

Authors:  Wissem Ben Mansoura; Sami Ben Rhouma; Myriam Jrad; Alia Zehani; Seifeddine Boukriba; Habiba Mizouni
Journal:  Urol Case Rep       Date:  2020-01-22

7.  Use and outcomes of kidneys from donors with renal angiomyolipoma: A systematic review.

Authors:  Desiree Garcia Anton; Karthik Kovvuru; Swetha R Kanduri; Narothama Reddy Aeddula; Tarun Bathini; Charat Thongprayoon; Wisit Kaewput; Karn Wijarnpreecha; Kanramon Watthanasuntorn; Sohail Abdul Salim; Praise Matemavi; Pradeep Vaitla; Franco Cabeza Rivera; Wisit Cheungpasitporn
Journal:  Urol Ann       Date:  2021-01-19

8.  Interventional treatment of renal angiomyolipoma: immediate results and clinical and radiological follow-up of 4.5 years.

Authors:  Poul Erik Andersen; Mie Gaedt Thorlund; Gjertrud Egge Wennevik; Rune Lau Pedersen; Lars Lund
Journal:  Acta Radiol Open       Date:  2015-07-13

9.  Embolization of hemorrhagic renal angiomyolipoma complicated by arteriovenous shunting: A case report.

Authors:  Michael J Mills; John Nguyen; Susan Jarosz; Mehran Salari; Patrick Hurley
Journal:  Radiol Case Rep       Date:  2018-08-07

10.  Renal Angiomyolipoma: The Good, the Bad, and the Ugly.

Authors:  Nicolas Vos; Raymond Oyen
Journal:  J Belg Soc Radiol       Date:  2018-04-20       Impact factor: 1.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.